Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Magnetic Resonance Spectroscopy × Clear all

Sponsor

Conditions

Breast Neoplasms 22 Prostatic Neoplasms 20 Carcinoma, Non-Small-Cell Lung 13 Glioma 12 Neoplasm Metastasis 11 Lymphoma 10 Glioblastoma 10 Neuroblastoma 9 Lung Neoplasms 8 Carcinoma, Renal Cell 8 Brain Neoplasms 8 Medulloblastoma 7 Ovarian Neoplasms 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Fallopian Tube Neoplasms 6 Carcinoma, Hepatocellular 6 Sarcoma 5 Rectal Neoplasms 5 Osteosarcoma 5 Neuroendocrine Tumors 5 Neoplasms 5 Melanoma 5 Ependymoma 5 Central Nervous System Neoplasms 5 Wilms Tumor 4 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Rhabdomyosarcoma 4 Rhabdoid Tumor 4

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡